Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
Q4 2025 vs. Q3 2025
How the institutions holding Lakefront Biotherapeutics NV changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 92 | 1 | 91 | 0 |
| Shares | 31.4M | 104.5K | 31.4M | +99.4K (+0.3%) |
| Value | $1.09B | $3.62M | $1.03B | −$53.5M (−4.9%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Lakefront Biotherapeutics NV at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Norges Bank | 90,000 | $2.94M | 0.00% |
| Kotler Kevin | 90,000 | $2.94M | 2.17% |
| Massar Capital Management, LP | 39,000 | $1.28M | 0.25% |
| Western Standard LLC | 32,000 | $1.05M | 0.48% |
| Acadian Asset Management LLC | 7,541 | $246.0K | 0.00% |
| Susquehanna International Group, LLP | 6,968 | $227.9K | 0.00% |
| Smartleaf Asset Management LLC | 389 | $12.7K | 0.00% |
| DV Equities, LLC | 332 | $10.9K | 0.00% |
| SageView Advisory Group, LLC | 80 | $2.62K | 0.00% |
| Bryn Mawr Trust Co | 36 | $1.18K | 0.00% |
| Bessemer Group Inc | 41 | $1.00K | 0.00% |
| Manning & Napier Advisors LLC | 26 | $848 | 0.00% |
| Signature Equity Partners, LLC | 22 | $719 | 0.00% |
| IMA Wealth, Inc. | 15 | $490 | 0.00% |
| Huntington National Bank | 4 | $131 | 0.00% |
| Caitong International Asset Management Co., Ltd | 4 | $131 | 0.00% |
Sold out (16)
Institutions that held Lakefront Biotherapeutics NV at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Primecap Management Co | 50,500 | $1.75M |
| Matauro, LLC | 47,536 | $1.65M |
| Suvretta Capital Management, LLC | 37,111 | $1.29M |
| Verition Fund Management LLC | 20,270 | $702.2K |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 17,469 | $605.1K |
| National Bank of Canada | 14,281 | $493.5K |
| Jane Street Group, LLC | 9,049 | $313.5K |
| HRT Financial LP | 8,697 | $301.0K |
| Brinker Capital Investments, LLC | 7,261 | $251.5K |
| JustInvest LLC | 6,106 | $211.5K |
| Squarepoint Ops LLC | 6,099 | $211.3K |
| Principal Securities, Inc. | 184 | $6.37K |
| Rockefeller Capital Management L.P. | 35 | $1.21K |
| UMA Financial Services, Inc. | 24 | $832 |
| Ronald Blue Trust, Inc. | 10 | $346 |
| Montag A & Associates Inc | 6 | $208 |
Not filed for Q4 2025 yet (1)
Institutions that held Lakefront Biotherapeutics NV at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Cubist Systematic Strategies, LLC | 104,539 | $3.62M |